Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$17,500.00

The Influence of the Gut Microbiota During Protracted Opioid Withdrawal

EF 2021-22

Résumé
Canada is currently facing an opioid crisis, with approximately 20 Canadians dying daily due to opioid overdose. Relapse following treatment for opioid addiction is common, and novel strategies are needed to reduce the likelihood of relapse. This project aims to explore the gut microbiome as a possible target for treatment during opioid withdrawal. Not only has the acute phase of opioid withdrawal been shown to alter the gut microbiota in mice, but fecal transfers from opioid-withdrawn to drug-naive mice are able to induce symptoms of opioid withdrawal. However, it has yet to be determined if the relationship between the microbiome and opioid withdrawal symptoms is sustained during longer periods of abstinence. This project aims to characterize the protracted opioid withdrawal phenotype in mice, and to determine if alterations in the microbiome are necessary for this phenotype to occur. This will include characterization of the symptoms of protracted withdrawal in mice, including mechanical and thermal hyperalgesia (assessed via von Frey filaments and tail-withdrawal assays, respectively), anxiety (using an elevated plus maze and open field test), and neuroinflammation in post-mortem tissue. Fecal samples from drug-naïve animals, as well as animals in various stages of opioid withdrawal, will be used to assess changes in the gut microbiota, and fecal matter from mice in various stages of opioid withdrawal will be used in fecal transfers to recolonize the gastrointestinal tract of germ-free mice. If the relationship between the gut microbiome and symptoms of withdrawal persists, interventions that aim to restore the composition of the gut microbiome could prove to be an attractive target in alleviating the withdrawal symptoms associated with chronic opioid use.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
466887
Name
Nickols Julia E
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Influence of the Gut Microbiota During Protracted Opioid Withdrawal
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Addiction; Analgesia; Hyperalgesia; Mental Health; Microbiome; Microglia; Neuroinflammation; Opioids; Reward; Withdrawal
Abstract
Canada is currently facing an opioid crisis, with approximately 20 Canadians dying daily due to opioid overdose. Relapse following treatment for opioid addiction is common, and novel strategies are needed to reduce the likelihood of relapse. This project aims to explore the gut microbiome as a possible target for treatment during opioid withdrawal. Not only has the acute phase of opioid withdrawal been shown to alter the gut microbiota in mice, but fecal transfers from opioid-withdrawn to drug-naive mice are able to induce symptoms of opioid withdrawal. However, it has yet to be determined if the relationship between the microbiome and opioid withdrawal symptoms is sustained during longer periods of abstinence. This project aims to characterize the protracted opioid withdrawal phenotype in mice, and to determine if alterations in the microbiome are necessary for this phenotype to occur. This will include characterization of the symptoms of protracted withdrawal in mice, including mechanical and thermal hyperalgesia (assessed via von Frey filaments and tail-withdrawal assays, respectively), anxiety (using an elevated plus maze and open field test), and neuroinflammation in post-mortem tissue. Fecal samples from drug-naïve animals, as well as animals in various stages of opioid withdrawal, will be used to assess changes in the gut microbiota, and fecal matter from mice in various stages of opioid withdrawal will be used in fecal transfers to recolonize the gastrointestinal tract of germ-free mice. If the relationship between the gut microbiome and symptoms of withdrawal persists, interventions that aim to restore the composition of the gut microbiome could prove to be an attractive target in alleviating the withdrawal symptoms associated with chronic opioid use.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Nickols, Julia E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~